EVMN
EVMN clinical trials: Evommune, Inc.
Every trial on ClinicalTrials.gov where Evommune, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 7
- Trials linked
- 6
- As lead sponsor
- 1
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
EVMN on the catalyst calendar · EVMN registry changes
- Primary completion Oct 2027Sponsor estimatePhase 2NCT07616128Study of EVO756 in Adults With MigraineEvommune, Inc. · MigraineRecruitingEVMNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 23, 2026ActualPhase 2NCT07150845Phase 2b Study of EVO756 in Adults With Atopic DermatitisEvommune, Inc. · Atopic DermatitisCompletedEVMNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 29, 2026ActualPhase 2NCT06873516Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU)Evommune, Inc. · Chronic Spontaneous UrticariaCompletedEVMNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 8, 2025ActualPhase 2NCT06603220A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults With Chronic Inducible UrticariaEvommune, Inc. · Chronic Inducible UrticariaCompletedEVMNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 17, 2025ActualPhase 2NCT06723405Efficacy Study of EVO301 in Moderate to Severe Atopic DermatitisEvommune, Inc. · Atopic Dermatitis (AD)CompletedEVMNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 27, 2023ActualPhase 2NCT05579899Safety and Efficacy Study of EVO101 Topical Cream in Atopic DermatitisEvommune, Inc. · Atopic Dermatitis EczemaCompletedEVMNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2025Sponsor estimateEarly Phase 1NCT06645821Participants with Mild to Moderate Hidradenitis Suppurativa Will Receive EVO101 a Topical Cream 0.1%Virginia Clinical Research, Inc. · Hidradenitis Suppurativa (HS)RecruitingEVMNCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 7 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner